These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9438700

  • 1. Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus.
    Ajani JA.
    Chest; 1998 Jan; 113(1 Suppl):112S-119S. PubMed ID: 9438700
    [Abstract] [Full Text] [Related]

  • 2. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
    Heath EI, Burtness BA, Heitmiller RF, Salem R, Kleinberg L, Knisely JP, Yang SC, Talamini MA, Kaufman HS, Canto MI, Topazian M, Wu TT, Olukayode K, Forastiere AA.
    J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
    [Abstract] [Full Text] [Related]

  • 3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 4. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM, Colarusso P, Goldberg M, Dresler C, Coia LR.
    Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [Abstract] [Full Text] [Related]

  • 5. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR, Greco FA, Meluch AA, Lane CM, Farley C, Gray JR, Clark BL, Burris HA, Hainsworth JD.
    J Clin Oncol; 2010 May 01; 28(13):2213-9. PubMed ID: 20351330
    [Abstract] [Full Text] [Related]

  • 6. Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study).
    Nakamura K, Kato K, Igaki H, Ito Y, Mizusawa J, Ando N, Udagawa H, Tsubosa Y, Daiko H, Hironaka S, Fukuda H, Kitagawa Y, Japan Esophageal Oncology Group/Japan Clinical Oncology Group.
    Jpn J Clin Oncol; 2013 Jul 01; 43(7):752-5. PubMed ID: 23625063
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
    Ando N, Ozawa S, Kitajima M, Iizuka T.
    Gan To Kagaku Ryoho; 1995 Jun 01; 22(7):869-76. PubMed ID: 7540823
    [Abstract] [Full Text] [Related]

  • 10. Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma.
    Urba SG, Orringer MB, Ianettonni M, Hayman JA, Satoru H.
    Cancer; 2003 Nov 15; 98(10):2177-83. PubMed ID: 14601087
    [Abstract] [Full Text] [Related]

  • 11. The use of mitomycin in esophageal cancer.
    Coia LR.
    Oncology; 1993 Apr 15; 50 Suppl 1():53-60. PubMed ID: 8483558
    [Abstract] [Full Text] [Related]

  • 12. [Radio- and chemotherapy of cancer of the esophagus].
    Tiret E.
    Rev Prat; 1999 Jun 01; 49(11):1186-91. PubMed ID: 10416350
    [Abstract] [Full Text] [Related]

  • 13. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma.
    Xia Y, Li YH, Chen Y, Zhang JH, Liu Q, Deng JY, Ai TS, Zhu HT, Fan JH, Badakhshi H, Zhao KL.
    Radiat Oncol; 2017 Mar 07; 12(1):47. PubMed ID: 28270162
    [Abstract] [Full Text] [Related]

  • 15. Treatment of locoregional esophageal cancer.
    Forastiere AA.
    Semin Oncol; 1992 Aug 07; 19(4 Suppl 11):57-63. PubMed ID: 1509282
    [Abstract] [Full Text] [Related]

  • 16. Preoperative hyperthermia combined with radiotherapy and chemotherapy for patients with incompletely resected carcinoma of the esophagus.
    Matsufuji H, Kuwano H, Kai H, Matsuda H, Sugimachi K.
    Cancer; 1988 Sep 01; 62(5):889-94. PubMed ID: 3409171
    [Abstract] [Full Text] [Related]

  • 17. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus.
    Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S.
    J Thorac Cardiovasc Surg; 1988 Aug 01; 96(2):242-8. PubMed ID: 2456424
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).
    Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, Ikeda K, Kanda T, Tsujinaka T, Nakamura K, Fukuda H.
    Ann Surg Oncol; 2012 Jan 01; 19(1):68-74. PubMed ID: 21879261
    [Abstract] [Full Text] [Related]

  • 19. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma.
    Adelstein DJ, Rice TW, Becker M, Larto MA, Kirby TJ, Koka A, Tefft M, Zuccaro G.
    Cancer; 1997 Sep 15; 80(6):1011-20. PubMed ID: 9305700
    [Abstract] [Full Text] [Related]

  • 20. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
    Ohtsu A.
    Gan To Kagaku Ryoho; 1998 Jan 15; 25(2):232-40. PubMed ID: 9474933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.